Table 2.
Term | Coefficient (standard error) | 95% confident interval | P-value |
---|---|---|---|
Proportion of people aged 15–64 | −0.0019 (0.0107) | (−0.0231, 0.0194) | 0.863 |
Population in 2018 (100 million of people) | 0.0002 (0.0242) | (−0.0478, 0.0481) | 0.995 |
Proportion of females in population (%) | 0.0006 (0.0199) | (−0.0388, 0.0400) | 0.976 |
Life expectancy at birth (years) | −0.0040 (0.0122) | (−0.0282, 0.0201) | 0.741 |
Neonatal mortality rate (%) | 0.0108 (0.0075) | (−0.0040, 0.0256) | 0.150 |
Mortality from CVD, cancer, diabetes or CRD between ages 30 and 70 (%) | −0.0071 (0.0109) | (−0.0286, 0.0144) | 0.514 |
Cause of death by injury (% of total) | 0.0017 (0.0128) | (−0.0238, 0.0271) | 0.898 |
Hypertension prevalence (%) | 0.0037 (0.0061) | (−0.0083, 0.0157) | 0.539 |
Diabetes prevalence (% of population aged 20–79) | 0.0013 (0.0130) | (−0.0245, 0.0271) | 0.921 |
Number of physicians (per 1000 people) | −0.0518 (0.0652) | (−0.1809, 0.0773) | 0.428 |
Immunization, measles (% of children aged 12–23 months) | −0.0056 (0.0035) | (−0.0126, 0.0013) | 0.113 |
BCG immunization strategy (binary) | −0.3258 (0.2278) | (−0.7768, 0.1251) | 0.155 |
Number of days since the first case of COVID-19 | 0.0000 (0.0022) | (−0.0045, 0.0044) | 0.992 |
BCG, Bacillus Calmette–Guérin; CRD, chronic respiratory disease; CVD, cardiovascular diseases.